Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia

TerminatedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Community-Acquired Pneumonia

Interventions

DRUG

Azithromycin SR

Azithromycin SR, 2.0 g PO x 1 dose for treatment period

DRUG

Amoxiclav

Amoxiclav 1000 x twice daily, 10 days duration